Omalizumab use in pregnancy showed comparable birth results with asthma … – Healio

Omalizumab use in pregnancy showed comparable birth results with asthma
Healio
Prevalence of congenital defects, prematurity and low birth weight in infants of mothers treated with omalizumab during pregnancy were comparable with the general population with asthma, according to recent study results. “Asthma affected 8.4% to 8.8

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.